hepat
c
viru
hcv
infect
major
caus
chronic
liver
diseas
becom
global
health
threat
hcv
vaccin
current
avail
treatment
antivir
therapi
associ
advers
side
effect
moreov
prevent
therapi
recurr
hepat
c
post
liver
transplant
serin
proteas
necessari
hcv
replic
repres
prime
target
develop
anti
hcv
therapi
recent
describ
therapeut
approach
erad
hcv
infect
cell
base
protein
deliveri
two
proteaseactivat
recombin
toxin
name
zymoxin
toxin
inactiv
fusion
ration
design
inhibitori
peptid
via
linker
deliv
cell
proteas
present
inhibitori
peptid
remov
result
reactiv
cytotox
activ
zymoxin
describ
suffer
two
limit
requir
high
level
proteas
activ
basal
activ
unactiv
form
result
narrow
potenti
therapeut
window
present
solut
overcam
major
limit
first
gener
zymoxin
convert
mazf
ribonucleas
toxic
compon
e
coli
chromosom
mazef
toxinantitoxin
system
zymoxin
introduc
cell
mean
gene
deliveri
construct
express
cassett
encod
singl
polypeptid
incorpor
toxin
fragment
potent
natur
antidot
maze
link
via
linker
coval
pair
inhibitor
ribonucleas
well
toler
express
healthi
cell
contrast
activ
proteolysi
induc
even
low
level
result
erad
express
model
cell
hcv
infect
cell
zymoxin
may
thu
becom
valuabl
tool
erad
cell
infect
intracellular
pathogen
express
intracellular
proteas
hepat
c
viru
hcv
small
envelop
rna
viru
belong
hepaciviru
genu
flavivirida
famili
hcv
recogn
major
caus
chronic
liver
diseas
affect
approxim
million
peopl
worldwid
present
time
persist
infect
associ
develop
chronic
hepat
cirrhosi
hepatocellular
carcinoma
protect
vaccin
hcv
yet
avail
even
recent
combin
antivir
therapi
often
poorli
toler
hcv
genom
encod
one
larg
open
read
frame
translat
polyprotein
proteolyt
process
yield
viral
structur
nonstructur
ns
protein
nonstructur
protein
includ
ion
channel
proteas
serin
proteaserna
helicas
cofactor
protein
rnadepend
rna
polymeras
rdrp
two
viral
encod
proteas
particip
polyprotein
process
autoproteas
cleav
ci
junction
serin
proteas
cleav
four
downstream
ns
protein
junction
extens
studi
hcv
protein
possess
multipl
enzymat
activ
essenti
hcv
replic
make
attract
target
anti
hcv
drug
develop
nterminu
complex
endoplasm
reticulum
er
membraneanchor
cofactor
primarili
function
serin
proteas
cleav
viral
polyprotein
precursor
downstream
remain
protein
helicas
ntpase
activ
essenti
hcv
replic
zymogen
inact
enzym
precursor
convert
activ
form
follow
biochem
modif
proteolyt
process
among
known
import
group
enzym
proteolyt
activ
secret
digest
enzym
like
pepsin
trypsin
cystein
aspart
acid
proteas
caspas
play
essenti
role
variou
stage
apoptot
process
blood
coagul
factor
recent
describ
proof
concept
potenti
new
antivir
agent
specif
erad
viral
infect
cell
thu
limit
viru
product
spread
agent
name
zymoxin
zymogen
toxin
compos
fusion
bind
transloc
domain
pseudomona
exotoxin
modifi
catalyt
domain
bacteri
plant
toxin
diphtheria
toxin
dta
ricin
toxin
rta
respect
upon
bind
transloc
cell
cytoplasm
virtu
correspond
pseudomona
exotoxin
domain
activ
toxin
mediat
proteas
cleavag
separ
toxic
domain
fuse
ration
design
inhibitori
peptid
zymoxin
show
higher
level
cytotox
appli
express
cell
hcv
infect
cell
demonstr
potenti
therapeut
window
still
zymoxin
describ
two
limit
first
requir
high
level
proteas
effici
activ
second
total
inact
zymogen
state
basal
cytotox
activ
without
proteolyt
activ
result
quit
narrow
therapeut
window
appar
zymoxin
partial
inhibit
ration
design
inhibitori
peptid
toxic
protein
complet
inhibit
natur
inhibitor
found
bacteri
toxinantitoxin
system
natur
bacteri
plasmid
ensur
surviv
within
bacteri
host
replic
insid
host
cell
use
mechan
function
segreg
prior
cell
divis
addit
sever
low
copi
number
plasmid
use
uniqu
system
call
addict
modul
toxinantitoxin
ta
system
function
prevent
prolifer
plasmidfre
cell
execut
call
postsegreg
kill
effect
system
consist
pair
gene
encod
stabl
toxin
unstabl
antitoxin
organ
bicistron
operon
transcript
autoregul
either
toxinantitoxin
complex
antitoxin
alon
coexpress
plasmid
harbor
cell
antitoxin
compon
interfer
lethal
action
toxin
cell
lose
plasmid
cellular
concentr
labil
antitoxin
degrad
faster
stabl
toxin
rapidli
diminish
enabl
toxin
exert
action
eventu
result
cell
death
review
toxinantitoxin
system
also
found
integr
chromosom
variou
bacteria
speci
function
subject
consider
specul
one
studi
genom
ta
modul
found
chromosom
e
coli
neg
autoregul
bicistron
operon
system
activ
sever
stress
condit
denot
mazef
two
activ
protein
compon
long
live
mazf
toxin
labil
maze
antitoxin
mazf
induc
toxic
execut
block
denovo
protein
synthesi
endoribonucleas
activ
catalyz
cleavag
singlestrand
mrna
aca
sequenc
coexpress
mazf
maze
antitoxin
complex
toxin
catalyt
inact
heterohexam
form
maze
dimer
sandwich
two
mazf
dimer
mazf
maze
mazf
review
crystal
structur
mazemazf
complex
indic
interact
toxin
antitoxin
primarili
mediat
acid
c
terminu
maze
wrap
around
mazf
homodim
cross
edg
dimer
interfac
later
li
et
al
discov
short
acid
peptid
correspond
maze
ctermin
aminoacid
denot
mazep
bind
strongli
homodim
mazf
possess
two
ident
activ
site
interestingli
found
one
inhibitori
peptid
occupi
singl
activ
site
mazf
homodim
affect
conform
site
consequ
becom
catalyt
inact
uniqu
mechan
also
explain
inhibitori
activ
maze
toward
mazf
molar
ratio
discoveri
mazf
mechan
action
soon
follow
demonstr
also
toxic
eukaryot
cell
caus
bakdepend
program
cell
death
mammalian
cell
suggest
may
use
tool
gene
therapi
diseas
cancer
aid
describ
design
differ
zymoxin
describ
base
mazf
ribonucleas
deliv
transgen
adenovir
vector
deliv
transgen
encod
fusion
mazf
potent
inhibitori
peptid
deriv
natur
antidot
maze
cleavabl
linker
show
selfinhibit
zymogen
toxin
well
toler
express
cell
contrast
express
hcv
infect
cell
cleavag
separ
toxin
inhibitor
result
inhibit
protein
synthesi
follow
death
cell
final
demonstr
treatment
mazf
base
zymoxin
cure
effect
appli
mix
cultur
healthi
hcv
infect
cell
lead
specif
erad
infect
cell
popul
construct
mazf
base
zymoxin
mazf
code
sequenc
fuse
c
terminu
hcv
cleavag
sequenc
deriv
genotyp
strain
junction
short
inhibitori
peptid
correspond
maze
ctermin
aminoacid
encompass
aminoacid
inhibitori
peptid
mazep
describ
li
et
al
fuse
preced
short
flexibl
linker
c
terminu
cleavag
site
sequenc
flexibl
linker
follow
ctermin
er
membran
anchor
tyrosin
phosphatas
fuse
c
terminu
inhibitori
peptid
whole
construct
fuse
n
terminu
monomer
red
fluoresc
protein
mcherri
see
figur
rational
behind
design
construct
denot
activ
mazf
coupl
ribonucleas
antidot
may
enabl
high
level
express
nontox
fusion
er
membran
uninfect
mammalian
cell
without
caus
deleteri
effect
contrast
hcv
infect
cell
fusion
protein
expect
coloc
er
membranebound
viral
proteas
infect
cell
local
cytosol
side
er
membran
membran
erlik
modifi
compart
result
linker
toxin
inhibitori
peptid
expect
cleav
toxic
ribonucleas
longer
coval
tether
er
membraneanchor
inhibitor
free
diffus
cytoplasm
lack
antidot
exert
cytotox
activ
final
fusion
fluoresc
protein
mcherri
make
whole
construct
trackabl
facilit
determin
express
level
intracellular
local
fluoresc
microscopi
control
uncleav
construct
denot
mcherryuncleav
mazf
construct
cleavag
sequenc
replac
mutat
amino
acid
cleavag
sequenc
hcv
genotyp
junction
valin
substitut
alanin
cystein
glycin
cystein
glycin
tyrosin
alanin
schemat
represent
mazfbas
zymoxin
activ
mazf
hypothet
mechan
cleavag
proteas
cytoplasm
side
er
membran
shown
figur
aminoacid
sequenc
mazf
base
zymoxin
found
text
verifi
express
activ
mazf
toler
cell
express
proteas
coloni
format
assay
carri
assay
toxic
express
transgen
compar
qualit
assess
test
effect
compet
transfect
cell
evolv
coloni
select
trex
cell
transfect
plasmid
encod
either
activ
mazf
mcherri
fluoresc
protein
egfpmazf
mazf
fuse
inhibitori
peptid
hour
h
later
express
encod
transgen
confirm
fluoresc
microscopi
data
shown
transfect
cell
seed
fold
dilut
treat
three
plasmid
confer
resist
day
select
surviv
coloni
stain
shown
figur
similar
number
surviv
coloni
observ
cell
transfect
plasmid
encod
activ
mazf
red
fluoresc
protein
alon
suggest
express
ribonucleas
trex
cell
express
caus
minim
toxic
expect
growth
sever
inhibit
cell
transfect
egfpfus
activ
uninhibit
toxin
er
membranetarget
zymoxin
coloc
proteas
vivo
previous
describ
cell
line
induc
express
addit
tetracyclin
fusion
egfp
code
sequenc
full
length
includ
helicas
domain
follow
hcv
genotyp
cell
denot
tetinduc
full
express
cell
stabli
transfect
plasmid
encod
zymoxin
activ
mazf
uncleav
control
mcherryuncleav
mazf
encod
plasmid
follow
select
stabl
clone
constitut
express
high
level
cleavabl
construct
denot
mazf
cell
uncleav
control
denot
mazf
cell
isol
order
character
intracellular
distribut
mcherri
fuse
zymoxin
uncleav
mazf
cell
subject
immunofluoresc
microscopi
analysi
shown
figur
b
zymoxin
similar
cellular
distribut
coloc
er
marker
calnexin
juxtanuclear
region
er
importantli
upon
induc
express
mazf
cell
coloc
two
fluoresc
fusion
protein
could
observ
figur
c
observ
confirm
inde
proteas
modifi
ribonucleas
tether
common
cellular
compart
presum
cytoplasm
side
er
membran
see
scheme
figur
sinc
express
activ
mazf
found
inhibit
denovo
protein
synthesi
mammalian
cell
hypothes
effect
may
observ
also
cell
mazf
base
zymoxin
proteolyt
activ
order
valid
assumpt
mazf
mazf
cell
supplement
tetracyclin
h
left
untreat
level
denovo
protein
synthesi
determin
h
leucin
incorpor
assay
shown
figur
upper
panel
complet
shutoff
protein
synthesi
observ
soon
h
post
induct
cell
express
cleavabl
construct
indic
proteolyt
activ
zymoxin
expect
protein
synthesi
impair
follow
induct
cell
express
uncleav
toxin
figur
schemat
represent
construct
activ
mazf
hypothet
mechan
activ
proteas
mazf
zymoxin
construct
fuse
element
follow
order
n
terminu
monomer
red
fluoresc
protein
mcherri
e
coli
mazf
ribonucleas
hcv
cleavag
sequenc
deriv
genotyp
strain
junction
short
inhibitori
peptid
correspond
maze
ctermin
aminoacid
encompass
aminoacid
inhibitori
peptid
mazep
describ
li
et
al
ctermin
er
membran
anchor
tyrosin
phosphatas
anchor
er
membran
cleavag
site
locat
ribonucleas
inhibitori
peptid
activ
mazf
construct
activ
dimer
conveni
illustr
monomer
form
cleav
proteas
also
local
cytoplasm
side
er
membran
toxic
ribonucleas
longer
coval
tether
eranchor
inhibitor
free
diffus
cytoplasm
lack
antidot
exert
destruct
activ
support
find
immunoblot
assay
reveal
near
complet
cleavag
zymoxin
follow
tetracyclineinduc
express
proteas
mazf
express
cell
figur
lower
panel
presum
proteolyt
activ
ribonucleas
toxin
result
cessat
cellular
protein
synthesi
soon
induct
explain
detect
rel
low
level
proteas
cell
expect
zymoxin
cleavag
could
detect
cell
express
uncleav
form
toxin
faint
band
correspond
cleav
zymoxin
also
detect
uninduc
cell
express
cleavabl
construct
cleavag
attribut
leaki
tet
induc
system
allow
low
figur
coloni
format
assay
assess
activ
mazf
cytotox
toward
cell
day
transfect
trex
cell
seed
per
well
well
plate
subsequ
transfect
mg
plasmid
encod
either
activ
mazf
mcherri
fluoresc
protein
egfpmazf
mazf
fuse
inhibitori
peptid
hour
later
transfect
effici
assess
fluoresc
microscopi
determin
equal
plasmid
transfect
cell
trypsin
count
seed
fold
dilut
start
cellswel
well
plate
incub
day
presenc
mgml
three
plasmid
confer
resist
surviv
coloni
fix
stain
giemsa
upper
panel
number
surviv
coloni
well
seed
cell
determin
manual
count
bar
repres
mean
standard
deviat
sd
set
data
two
well
lower
panel
zymoxinmedi
remov
hcv
infect
cell
plo
one
wwwplosoneorg
basal
transcript
proteas
absenc
extern
ad
tetracyclin
cleavag
could
detect
cell
follow
transfect
substrat
encod
transgen
data
shown
appar
low
basal
proteolyt
activ
well
toler
activ
zymoxin
express
cell
show
indic
denovo
protein
synthesi
inhibit
comparison
cell
express
uncleav
toxin
see
cpm
valu
upper
panel
figur
evalu
potenti
mazf
base
zymoxin
erad
express
cell
three
well
plate
seed
tetinduc
full
mazf
mazf
cell
supplement
fold
serial
dilut
tetracyclin
start
ng
ml
h
rel
fraction
viabl
cell
determin
use
enzymat
mtt
assay
shown
figur
lower
panel
express
level
roughli
tune
modul
final
tetracyclin
concentr
growth
figur
inhibit
denovo
protein
synthesi
mazf
base
zymoxin
cell
activ
mazf
mazf
cell
seed
per
well
plate
h
later
cell
supplement
tetracyclin
final
concentr
ngml
left
untreat
h
tet
h
tet
tet
respect
h
seed
level
denovo
protein
synthesi
determin
h
leucin
incorpor
assay
describ
materi
method
result
express
percent
valu
obtain
cell
induc
express
proteas
tet
bar
repres
mean
sd
set
data
determin
triplic
number
bar
repres
mean
count
per
minut
cpm
valu
microgram
total
protein
sampl
upper
panel
microgram
total
protein
lysat
describ
cell
analyz
immunoblot
mous
antimcherri
detect
zymoxin
mous
antigfp
detect
mous
anti
actin
antibodi
load
control
follow
hrpconjug
secondari
antibodi
ecl
develop
solid
arrow
full
length
zymoxin
hollow
arrow
n
termin
portion
zymoxin
lower
panel
media
around
ngml
intermedi
concentr
induct
low
express
level
inde
strong
cytotox
clearli
evid
mazf
cell
treat
tetracyclin
concentr
ngml
cytotox
effect
detect
control
mazf
tetinduc
full
proteas
express
cell
similarli
treat
figur
upper
panel
find
demonstr
deleteri
effect
mazf
base
zymoxin
specif
toward
proteas
express
cell
well
compet
activ
low
cellular
level
proteas
order
obtain
visual
insight
cell
level
mazf
mazf
cell
supplement
tetracyclin
final
concentr
ngml
ngml
low
high
induct
level
express
respect
left
untreat
h
later
nuclei
stain
cell
examin
fluoresc
microscop
result
show
lower
higher
induct
level
proteas
caus
growth
inhibit
round
cell
constitut
express
cleavabl
mazf
furthermor
green
red
fluoresc
faint
cell
probabl
result
destruct
ribonucleas
activ
cleav
toxin
toward
proteas
mrna
expect
none
observ
evid
cell
supplement
tetracyclin
express
induc
high
level
cell
constitut
express
uncleav
toxin
figur
adenovirusmedi
deliveri
activ
mazf
encod
cassett
specif
erad
express
hepatocyt
achiev
effici
dna
deliveri
mammalian
cell
express
cassett
encod
activ
mazf
clone
first
gener
human
type
adenovir
vector
plasmid
dna
homolog
recombin
bacteria
viru
particl
propag
packag
cell
describ
materi
method
section
addit
control
adenovir
vector
construct
deliveri
similar
cassett
encod
h
cell
supplement
fold
dilut
tetracyclin
start
concentr
ngml
left
untreat
hour
later
fraction
viabl
cell
rel
untreat
control
determin
use
enzymat
mtt
assay
bar
repres
mean
set
data
six
well
lower
panel
ng
total
protein
lysat
mazf
cell
supplement
fold
dilut
tetracyclin
h
analyz
immunoblot
mous
antigfp
detect
mous
antiactin
antibodi
load
control
follow
hrpconjug
secondari
antibodi
ecl
develop
uncleav
version
construct
mcherryuncleav
mazf
redfluoresc
cometlik
adenovirusproduc
foci
appar
upon
infect
packag
cell
recombin
virus
encod
cleavabl
uncleav
construct
see
figur
product
yield
virus
plaqu
form
unit
pfu
ml
two
cycl
viru
amplif
see
text
order
evalu
abil
adenovirusmedi
deliveri
activ
mazf
encod
cassett
erad
express
hepatocyt
wildtyp
hepatoma
cell
previous
describ
egfpful
express
cell
infect
uncleav
mazf
encod
virus
sinc
previou
unpublish
observ
studi
other
indic
high
level
transgen
express
adenovir
infect
per
se
may
advers
affect
cell
viabil
growth
cell
infect
seri
multipl
infect
moi
ratio
order
find
optim
moi
lead
erad
cell
maintain
minim
toxic
cell
shown
figur
left
panel
infect
zymoxin
result
consider
cytotox
effect
hepatocyt
lead
almost
complet
erad
moi
howev
infect
ratio
also
advers
affect
growth
wildtyp
hepatocyt
contrast
infect
moi
decreas
viabil
cell
untreat
control
without
affect
viabil
wildtyp
hepatocyt
see
also
microscop
examin
figur
therefor
infect
moi
appli
next
experi
expect
substanti
enhanc
cytotox
express
cell
rel
wildtyp
cell
observ
moi
upon
infect
uncleav
mazf
encod
virus
figur
right
panel
adenovirusmedi
deliveri
mazf
encod
cassett
specif
erad
hcv
infect
hepatocyt
test
compet
mazf
base
zymoxin
specif
erad
hcv
infect
hepatocyt
util
infecti
chimer
viru
one
current
use
model
studi
hepat
c
viru
recombin
infecti
hcv
particl
produc
cell
cultur
hcvcc
review
see
main
purpos
zymoxin
base
treatment
specif
erad
hcv
infect
cell
background
healthi
cell
mix
cultur
experi
carri
experi
hepatoma
cell
infect
hcv
chimer
viru
encod
proteas
genotyp
strain
infect
reach
cultur
cell
show
express
hcvcore
protein
detect
immunostain
fluoresc
microscopi
mix
cultur
cultur
uninfect
cell
treat
activ
mazf
uncleavablemazf
encod
adenovirus
moi
control
cell
remain
untreat
h
post
adenovir
infect
viabil
assay
microscop
examin
includ
immunostain
hcvcore
protein
perform
shown
treat
mix
cultur
mazf
zymoxinencod
adenoviru
reduc
viabl
cell
popul
rel
untreat
control
viabil
uninfect
cell
hcv
neg
bare
affect
treatment
figur
upper
panel
microscop
examin
treat
mix
cultur
reveal
two
cell
popul
differ
appear
one
popul
character
typic
cell
morpholog
hollow
arrow
figur
lower
panel
compos
partial
detach
cell
round
condens
distort
shape
fill
arrow
hypothes
zymoxinintox
hcv
infect
cell
order
valid
assumpt
fraction
hcv
infect
cell
gener
popul
evalu
immunofluoresc
analysi
use
antihcv
core
protein
specif
antibodi
inde
treatment
zymoxin
show
cure
effect
upon
partial
infect
cultur
consider
reduc
fraction
hcv
infect
cell
gener
popul
figur
expect
signific
effect
upon
hcv
infect
cell
popul
observ
follow
treatment
uncleav
zymoxin
fight
viral
infect
consid
one
challeng
area
modern
medicin
vaccin
consid
effici
method
fight
viral
infect
viral
pathogen
caus
worldwid
health
problem
like
human
immunodefici
viru
hiv
hepat
c
viru
hcv
effici
vaccin
yet
develop
last
year
effort
focus
discoveri
develop
antivir
agent
target
crucial
step
viral
replic
cycl
includ
viral
entri
rna
translat
posttransl
process
revers
transcript
genom
integr
viral
assembl
releas
essenti
step
replic
cycl
mani
virus
process
polyprotein
precursor
viralencod
proteas
partial
list
human
diseas
associ
virus
encod
proteas
genom
includ
flavivirus
hepat
c
viru
hcv
west
nile
viru
wnv
dengu
fever
viru
dfv
yellow
fever
viru
yfv
retrovirus
picornavirus
coxsackieviru
polioviru
hepat
viru
nidovirus
coronavirus
cov
includ
sever
acut
respiratori
syndrom
sar
caus
sarscov
herpesvirus
varicellazost
viru
vzv
epsteinbar
viru
ebv
therefor
larg
part
antivir
drug
discoveri
focus
inhibit
viral
proteas
group
publish
sever
studi
hcv
replic
inhibit
intracellular
express
antibodi
peptid
aptam
opposit
side
coin
take
advantag
activ
viral
proteas
pers
antivir
approach
rather
neglect
recent
describ
studi
base
concept
sitoxin
antivir
agent
design
erad
viralinfect
cell
take
advantag
specif
viral
activ
instead
inhibit
specif
sitoxin
compris
effector
domain
eg
toxin
domain
bear
intracellular
signal
moieti
eg
degrad
intracellular
local
signal
domain
locat
effector
domain
domain
bear
intracellular
signal
moieti
specifi
cleavag
site
predetermin
proteas
eg
viral
encod
proteas
follow
introduct
sitoxin
target
cell
express
specif
proteas
cleavag
predetermin
proteas
separ
toxic
effector
domain
sitoxin
intracellular
signal
moieti
result
either
longerliv
therefor
toxic
effector
domain
effector
domain
move
cellular
compart
domain
nontox
cellular
compart
domain
abl
exert
effect
develop
success
evalu
two
ration
design
viralproteaseactiv
chimer
toxin
name
zymoxin
zymogen
toxin
contrast
sitoxin
inhibitori
activ
mediat
intracellular
compon
recogn
cleavabl
signal
polypeptid
fuse
constitut
activ
toxin
concept
zymoxin
base
idea
reengin
toxic
enzym
inact
zymogen
specif
activ
predetermin
proteas
gener
approach
demonstr
eleg
studi
sever
enzym
includ
bovin
rnase
maiz
ribosom
inactiv
protein
maizerip
convert
proteas
activ
form
previou
work
focus
design
proteindeliv
toxin
convert
proteaseactiv
form
mean
fusion
specif
ration
design
inhibitori
peptid
proteas
cleavabl
linker
test
invitro
hcv
infect
cell
clear
proteas
cleavagedepend
enhanc
activitycytotox
observ
howev
construct
two
major
drawback
mention
introduct
first
incomplet
inhibit
toxic
enzymat
activ
confer
ration
design
fuse
peptid
second
relat
necess
rel
high
level
express
viral
proteas
achiev
adequ
zymoxin
activ
insid
cell
current
studi
turn
evalu
similar
strategi
erad
hcvinfect
cell
name
convert
constitut
activ
enzym
activ
zymogen
toxic
moieti
chose
mazf
endoribonucleas
togeth
polypeptid
antidot
maze
constitut
one
studi
genom
toxinantitoxin
system
e
coli
order
convert
mazf
zymoxin
fusion
polypeptid
construct
inhibitori
peptid
deriv
maze
antitoxin
fuse
c
terminu
mazf
toxin
via
linker
regard
issu
incomplet
inhibit
zymoxin
activ
uncleav
form
mention
contrast
previous
describ
construct
ration
design
peptid
append
provid
inhibit
toxin
activ
mazf
basedzymoxin
natur
inhibitori
polypeptid
chosen
purpos
antidot
polypeptid
toxinantitoxin
system
evolutionari
shape
strongli
inhibit
destruct
activ
toxic
counterpart
thu
effici
inhibit
may
achiev
use
inhibitori
peptid
construct
zymoxin
inde
result
show
fuse
mazederiv
inhibitori
peptid
diminish
toxin
activ
extent
enabl
nonleth
overexpress
cell
order
improv
respons
zymoxin
presenc
low
level
cellularexpress
viral
proteas
er
membran
anchor
peptid
fuse
c
terminu
construct
subsequ
maze
deriv
inhibitori
peptid
use
design
coloc
erbound
proteas
zymoxin
substrat
might
achiev
result
improv
cleavag
effici
inde
coloc
could
observ
shown
figur
moreov
activ
zymoxin
evid
also
upon
express
low
cellular
level
viral
proteas
figur
also
mention
extrem
sensit
minut
amount
express
proteas
zymoxin
express
cell
still
toler
degre
activ
proteolysi
shown
mazf
express
cell
show
low
basal
proteolyt
activ
without
tetracyclin
induct
figur
properti
may
fact
contribut
specif
gener
safeti
zymoxinbas
therapeut
even
though
spontan
unspecif
proteolyt
activ
toward
substrat
could
detect
cell
experi
data
shown
discuss
tether
zymoxin
er
membran
inhibitori
peptid
may
also
enhanc
cleavagedepend
toxic
might
achiev
enabl
spatial
separ
activ
toxin
antidot
follow
diffus
activ
mazf
inhibitori
peptidefre
cytoplasm
support
assumpt
found
although
cleav
cytoplasm
version
mazf
base
zymoxin
bare
toxic
proteaseexpress
cell
data
shown
contrast
previou
studi
toxin
deliv
mammalian
cell
purifi
recombin
protein
current
research
adenovir
vector
genedeliveri
system
use
wide
appli
gene
therapi
recombin
viral
vaccin
basic
scienc
studi
system
enabl
effici
deliveri
high
level
transgen
express
wide
varieti
human
cell
use
system
demonstr
specif
erad
full
express
cell
spare
cell
express
proteas
furthermor
specif
erad
hcv
infect
cell
also
achiev
demonstr
promin
cure
effect
test
mix
cultur
healthi
hcv
infect
hepatocyt
use
viral
gene
deliveri
treat
hcv
infect
erad
infect
cell
prove
success
previou
studi
mice
chimer
human
liver
studi
hsu
et
al
design
modifi
proapoptot
bid
molecul
endogen
cleavag
site
replac
recognit
site
bid
requir
proteolyt
process
order
activ
apoptot
function
infect
adenovir
vector
deliv
transgen
encod
engin
bid
molecul
demonstr
induc
activ
apoptosi
cell
express
hcv
proteas
moreov
signific
reduct
hcv
titer
serum
hcv
infect
mice
detect
follow
inject
engin
adenovir
vector
jugular
vein
although
approach
prove
success
taken
account
deliv
transgen
encod
modifi
form
protein
natur
express
target
cell
potenti
neg
influenc
normal
cellular
process
endogen
counterpart
play
role
exampl
overexpress
noninfect
cell
apoptot
molecul
describ
may
act
domin
neg
compet
natur
endogen
protein
interact
activ
regul
substrat
deliveri
transgen
encod
foreign
protein
endogen
counterpart
target
cell
mazf
may
reduc
risk
furthermor
note
mazf
possess
ribonucleas
activ
also
capabl
process
multipl
potenti
cleavag
site
hcv
genom
although
evalu
studi
direct
attack
parasit
genet
materi
may
repres
addit
mode
antivir
activ
work
parallel
hostcel
protein
synthesi
shutoff
note
applic
describ
zymoxin
may
extend
replac
proteas
cleavag
site
separ
toxic
moieti
inhibitori
peptid
could
facilit
erad
cell
infect
proteas
express
virus
hcv
partial
list
proteas
express
virus
given
begin
discuss
differ
strain
hcv
differ
proteas
cleavag
specif
addit
one
may
replac
c
termin
er
anchor
peptid
sequenc
tether
construct
differ
intracellular
locat
viral
proteas
resid
way
coloc
zymoxin
predetermin
viral
proteas
may
achiev
conclus
present
antivir
agent
design
follow
previous
describ
zymoxin
concept
constitut
activ
toxin
convert
zymogen
viralproteas
activ
mazfbas
zymoxin
introduc
target
cell
mean
adenoviru
mediat
gene
deliveri
show
low
toxic
cell
enhanc
respons
low
viralproteas
express
level
compar
previous
present
construct
evid
result
mazf
base
zymoxin
erad
model
cell
hcv
infect
cell
remark
effici
specif
provid
proof
concept
zymoxin
potenti
new
mean
fight
viral
diseas
obvious
optim
pharmacolog
assess
anim
model
may
requir
order
determin
safeti
effici
zymoxin
treatment
context
whole
organ
follow
escherichia
coli
e
coli
strain
use
blue
stratagen
usa
plasmid
propag
stratagen
usa
gener
recombin
adenoviru
plasmid
dna
recombin
dna
techniqu
carri
accord
standard
protocol
recommend
supplier
nucleotid
sequenc
determin
use
prism
genet
analyz
appli
biosystem
usa
accord
supplier
recommend
eukaryot
cmv
promoterbas
gfpfusion
express
vector
pegfp
use
express
mcherri
mazf
mazfbas
zymoxin
clontech
usa
adeasi
plasmid
system
pshuttl
use
gener
recombin
human
type
adenovir
vector
gene
deliveri
zymoxin
express
cassett
gener
gift
prof
nadir
arber
integr
cancer
prevent
center
tel
aviv
souraski
medic
center
israel
plasmid
dna
fragment
purif
carri
highspe
plasmid
mini
kit
gelpcr
dna
fragment
extract
kit
geneaid
biotech
ltd
taiwan
unless
mention
otherwis
dna
ligas
restrict
enzym
purchas
new
england
biolab
usa
dna
ligat
carri
overnight
oligonucleotid
oligonucleotid
use
studi
purchas
hylab
israel
oligonucleotid
use
studi
list
tabl
construct
vector
encod
activ
mazf
polymeras
chain
reaction
pcr
carri
use
singl
coloni
escherichia
coli
strain
templat
forward
primer
revers
primer
pcr
product
encod
fusion
polypeptid
compos
n
terminu
mazf
hcv
cleavag
sequenc
deriv
genotyp
strain
junction
short
flexibl
linker
short
inhibitori
peptid
correspond
maze
ctermin
aminoacid
encompass
aminoacid
inhibitori
peptid
mazep
describ
li
et
al
flexibl
linker
ctermin
er
membran
anchor
tyrosin
phosphatas
digest
xhoi
ecori
clone
correspond
site
plasmid
gener
plasmid
activ
mazf
next
sequenc
red
fluoresc
protein
mcherri
amplifi
pcr
express
cassett
kindli
provid
prof
adi
avni
depart
molecular
biolog
ecolog
plant
telaviv
univers
israel
use
forward
primer
revers
primer
pcr
product
digest
nhei
xhoi
clone
correspond
site
plasmid
activ
mazf
replac
egfp
code
sequenc
gener
plasmid
activ
mazf
aminoacid
sequenc
encod
cleavabl
zymoxin
found
text
construct
vector
encod
mcherryuncleav
mazf
pcr
carri
use
dna
plasmid
activ
mazf
templat
forward
primer
revers
primer
pcr
product
digest
ecorv
nrui
digest
product
bp
clone
correspond
site
plasmid
use
templat
gener
plasmid
pmcherryuncleav
mazf
plasmid
encod
uncleav
construct
cleavag
sequenc
replac
mutat
amino
acid
cleavag
sequenc
hcv
genotyp
junction
valin
substitut
alanin
cystein
glycin
cystein
glycin
tyrosin
alanin
aminoacid
sequenc
encod
uncleav
zymoxin
found
text
construct
vector
encod
egfpmazf
mutat
variant
intermedi
vector
use
construct
process
activ
mazf
encod
vector
variant
nonsens
mutat
insert
instead
tyrosin
smsi
sequenc
recognit
site
gener
plasmid
pegfpmazf
encod
truncat
egfpmazf
fusion
protein
lack
maze
deriv
inhibitori
peptid
er
anchor
construct
vector
encod
mcherri
sequenc
red
fluoresc
protein
mcherri
amplifi
pcr
express
cassett
see
construct
vector
encod
activ
mazf
use
forward
primer
revers
primer
pcr
product
digest
nhei
bglii
clone
correspond
site
plasmid
pegfp
replac
egfp
code
sequenc
gener
plasmid
pmcherri
construct
propag
recombin
adenovir
vector
construct
propag
recombin
human
type
adenovir
vector
gene
deliveri
activ
mazf
mcherryuncleav
mazf
express
cassett
carri
use
adeasi
system
essenti
describ
detail
descript
procedur
provid
text
human
embryon
kidney
cell
stabli
express
tetracyclin
repressor
protein
trex
cell
line
invitrogen
usa
human
hepatoma
cell
use
throughout
studi
cell
line
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
calf
serum
fc
mm
lglutamin
uml
penicillin
mgml
streptomycin
biolog
industri
israel
humidifi
co
incub
calciumphosph
transfect
method
appli
introduc
mg
plasmid
activ
mazf
plasmid
pmcherryuncleav
mazf
trex
cell
induc
express
egfpful
seed
cell
per
mm
plate
h
transfect
stabl
transfect
induc
express
egfpful
constitut
express
activ
mazf
denot
mazf
cell
mcherryuncleav
mazf
denot
mazf
cell
select
medium
contain
mgml
ag
scientif
usa
cell
clone
express
high
level
cleavabl
construct
uncleav
control
identifi
fluoresc
microscopi
isol
protein
extract
h
posttransfect
cell
wash
pb
scrape
lyse
buffer
contain
mm
nacl
mm
edta
mm
tri
hcl
ph
proteas
inhibitor
cocktail
sigma
israel
follow
minut
incub
ice
lysat
clear
centrifug
g
minut
immunoblot
protein
sampl
electrophores
sdspolyacrylamid
gel
transfer
nitrocellulos
detect
use
mous
monoclon
antimcherri
antibodi
clontech
usa
mous
monoclon
antigfp
antibodi
santacruz
usa
mous
monoclon
antiactin
antibodi
abcam
usa
follow
horseradish
peroxidas
hrp
conjug
goat
antimous
antibodi
jackson
immunoresearch
laboratori
usa
enhanc
chemiluminesc
ecl
detect
use
supersign
west
pico
chemiluminesc
substrat
thermo
scientificpierc
usa
viru
assay
carri
intergenotyp
chimer
hepat
c
viru
hcv
produc
replac
segment
viru
genom
compar
segment
genotyp
viru
chimer
viru
kindli
provid
prof
stanley
lemon
univers
texa
galveston
contain
two
compensatori
mutat
promot
growth
cell
cultur
describ
previous
hcv
rna
transcrib
vitro
electropor
cell
essenti
describ
previous
brief
mg
vitrosynthes
hcv
rna
mix
cell
cuvett
puls
twice
kv
mf
cell
seed
plate
flask
passag
interv
posttransfect
trypsin
reseed
split
fresh
cultur
vessel
infect
reach
monitor
immunofluoresc
stain
anti
hcv
core
protein
mous
monoclon
antibodi
affin
bioreag
usa
goat
antimous
igg
jackson
immunoresearch
laboratori
usa
see
visual
hcv
infect
cell
infect
assay
mix
cultur
uninfect
hcv
infect
cell
ratio
taken
cytotox
assay
confoc
fluoresc
microscopi
analysi
trex
cell
induc
express
egfpful
constitut
express
activ
uncleav
mazf
mazf
mazf
cell
seed
polyllysin
coat
coverslip
wellplat
h
later
cell
supplement
mgml
tetracyclin
left
untreat
h
later
cell
fix
formaldehyd
pb
uninduc
cell
permeabil
triton
pb
minut
block
fetal
calf
pb
room
temperatur
minut
incub
dilut
rabbitpolyclon
anticalnexin
antibodi
sigma
usa
primari
antibodi
h
follow
dilut
antirabbit
igg
jackson
immunoresearch
laboratori
usa
secondari
antibodi
minut
nuclei
induc
uninduc
cell
stain
hoechst
h
room
temperatur
slide
wash
pb
mount
mowiol
solut
calbiochem
usa
immunostain
uninduc
cell
immuglo
mount
medium
immco
diagnost
usa
induc
mazf
cell
examin
use
zeiss
lsm
meta
laser
scan
confoc
microscop
visual
trex
cell
induc
express
egfpful
supplement
differ
tetracyclin
concentr
constitut
express
activ
mazf
mcherryuncleav
mazf
mazf
mazf
cell
seed
polyllysin
coat
coverslip
wellplat
h
later
cell
supplement
ngml
ngml
tetracyclin
left
untreat
h
later
cell
fix
formaldehyd
pb
follow
nuclear
stain
hoechst
h
room
temperatur
slide
wash
pb
mount
immuglo
mount
medium
examin
use
fluoresc
microscop
visual
cell
infect
recombin
adenoviru
encod
activ
mazf
mcherryuncleav
mazf
cell
seed
per
well
well
plate
cultur
reach
confluenc
growth
medium
replac
fresh
medium
contain
fold
dilut
recombin
adenovirus
encod
activ
mazf
mcherryuncleav
mazf
start
pfu
per
well
h
cell
fix
formaldehyd
pb
examin
use
fluoresc
microscop
visual
hcv
infect
cell
infect
assay
cell
infect
hcv
chimer
viru
seed
chamber
slide
nalg
nunc
usa
h
cell
fix
permeabil
acetonemethanol
mixtur
stain
dilut
mous
monoclon
antibodi
affin
bioreag
usa
specif
hcv
core
protein
follow
stain
dilut
goat
antimous
igg
jackson
immunoresearch
laboratori
usa
nuclei
stain
dapi
sigma
israel
slide
wash
pb
mount
southernbiotech
usa
examin
use
fluoresc
microscop
visual
zymoxintr
mix
cultur
uninfect
hcv
infect
cell
see
cytotox
assay
recombin
adenovirus
encod
activ
mazf
mcherryuncleav
mazf
mix
cultur
uninfect
hcvinfect
cell
coloni
format
assay
trex
cell
seed
per
well
well
plate
h
later
cell
transfect
mg
plasmid
activ
mazf
pmcherri
pegfpmazf
encod
activ
mazf
mcherri
fluoresc
protein
egfpmazf
mazf
fuse
inhibitori
peptid
respect
transfect
carri
use
fugen
reagent
roch
germani
accord
manufactur
instruct
h
transfect
effici
assess
fluoresc
microscopi
determin
equal
plasmid
transfect
cell
trypsin
count
seed
fold
dilut
start
cellswel
well
plate
incub
day
presenc
mgml
three
plasmid
confer
resist
surviv
coloni
fix
formaldehyd
pb
stain
giemsa
sigma
usa
number
surviv
coloni
well
seed
cell
determin
manual
count
cellkil
activ
mazf
uncleav
mazf
zymoxin
measur
thiazolyl
blue
tetrazoliam
bromid
mtt
assay
describ
cytotox
assay
intracellularli
express
activ
mazf
mcherryuncleav
mazf
trex
cell
induc
express
egfpful
tetinduc
full
mazf
mazf
cell
seed
well
plate
cell
per
well
h
cell
supplement
fold
dilut
tetracyclin
start
concentr
ngml
left
untreat
h
later
media
replac
fresh
media
ml
per
well
contain
mgml
mtt
thiazolyl
blue
tetrazoliam
bromid
sigma
israel
dissolv
pb
reagent
cell
incub
minut
mttformazan
crystal
dissolv
addit
extract
solut
sd
n
ndimethyl
formamid
dmf
ph
ml
per
well
incub
h
absorb
nm
record
autom
microtit
plate
reader
result
express
percentag
live
cell
rel
untreat
control
cytotox
assay
recombin
adenovirus
encod
activ
mazf
mcherryuncleav
mazf
full
express
cell
wildtyp
egfpful
express
cell
seed
per
well
well
plate
h
growth
media
replac
fresh
media
contain
recombin
adenovirus
encod
activ
mazf
mcherryuncleav
mazf
indic
multipl
infect
moi
ratio
control
cell
remain
untreat
four
day
post
infect
media
replac
fresh
media
ml
per
well
contain
mgml
mtt
except
repres
well
cell
fix
microscop
examin
cell
incub
minut
next
step
ident
these
describ
cytotox
assay
recombin
adenovirus
encod
activ
mazf
mcherryuncleav
mazf
mix
cultur
uninfect
hcvinfect
cell
uninfect
cell
mix
cultur
hcv
infect
uninfect
cell
ratio
infect
cultur
seed
plate
cellswel
h
cell
treat
recombin
adenovirus
moi
encod
activ
mazf
mcherryuncleav
mazf
zymoxin
control
cell
remain
untreat
h
later
media
replac
fresh
media
ml
per
well
contain
mgml
mtt
except
repres
well
cell
fix
microscop
examin
cell
incub
minut
next
step
ident
describ
hcvinfect
immunofluoresc
analysi
cell
hcv
infect
uninfect
mix
cultur
seed
per
well
chamber
slide
nalg
nunc
usa
h
later
cell
treat
recombin
adenovirus
moi
encod
activ
mazf
mcherryuncleav
mazf
zymoxin
control
cell
remain
untreat
h
post
treatment
cell
fix
permeabil
acetonemethanol
mixtur
stain
dilut
mous
monoclon
antibodi
affin
bioreag
usa
specif
hcv
core
protein
follow
stain
dilut
fitcconjug
goat
antimous
igg
jackson
immunoresearch
laboratori
usa
nuclei
stain
dapi
slide
mount
southernbiotech
usa
examin
use
fluoresc
microscop
treatment
evalu
fraction
hcvinfect
cell
gener
cell
popul
perform
divid
number
green
hcvcore
posit
cell
gener
number
cell
dapi
stain
five
repres
microscop
field
h
leucin
incorpor
assay
mazf
mazf
cell
seed
per
well
plate
h
later
cell
supplement
tetracyclin
final
concentr
ngml
left
untreat
h
seed
cell
supplement
h
leucin
perkin
elmer
usa
final
concentr
mciml
return
incub
h
cell
scrape
wash
pb
lyse
four
freezethaw
cycl
mg
total
protein
form
lysat
treatment
add
solut
contain
pb
final
concentr
mg
bovin
serum
albumin
bsa
total
volum
ml
solut
mix
ident
volum
icecold
trichloro
acet
acid
tca
mixtur
incub
ice
minut
centrifug
minut
g
pellet
wash
icecold
tca
follow
wash
icecold
ethanol
pellet
dissolv
ml
naoh
transfer
scintil
tube
neutral
ml
hcl
ml
scintil
liquid
ad
radioact
count
betacount
devic
figur
fluoresc
microscopi
analysi
adenoviru
produc
foci
cell
seed
per
well
well
plate
reach
confluenc
cell
infect
fold
dilut
recombin
adenovirus
encod
activ
mazf
mcherryuncleav
mazf
start
pfu
per
well
h
cell
fix
examin
fluoresc
microscop
red
fluoresc
adenovirusproduc
foci
well
infect
pfu
shown
bar
repres
mm
tabl
oligonucleotid
use
studi
text
aminoacid
sequenc
mazf
base
zymoxin
text
construct
propag
recombin
adenovir
vector
stanley
lemon
univers
texa
galveston
usa
hcvcc
clone
thank
prof
nadir
arber
integr
cancer
prevent
center
tel
aviv
souraski
medic
center
israel
adeasi
plasmid
system
use
gener
recombin
human
type
adenovir
vector
